Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives

Amedea B Seabra, Renata de Lima, Marcelo Calderón1

  • 1Exact and Earth Science Department, Universidade Federal de São Paulo, Rua São Nicolau, 210, Centro, Diadema, SP, CEP 09913030, Brazil. amedea.seabra@gmail.com.

Insights

Nitric oxide (NO) has dual roles in cancer. This review explores NO-releasing nanomaterials, like nanoparticles and liposomes, for targeted cancer therapy, harnessing NO

Area of Science:

  • Biomedical Engineering
  • Cancer Biology
  • Nanotechnology

Background:

  • Nitric oxide (NO) exhibits dual effects in cancer, promoting or inhibiting tumor growth based on concentration.
  • High concentrations of NO can induce tumor cell cytotoxicity and apoptosis, suggesting therapeutic potential.

Purpose of the Study:

  • To review the multifaceted roles of nitric oxide (NO) in cancer biology.
  • To highlight the therapeutic promise of NO-releasing nanomaterials for cancer treatment.

Main Methods:

  • Literature review focusing on the biological effects of NO in cancer.
  • Analysis of various NO-releasing nanomaterial platforms, including polymeric nanoparticles, dendritic polymers, liposomes, silica nanoparticles, metallic nanoparticles, and quantum dots.

Main Results:

  • NO concentration dictates its effect on cancer, with high levels being tumor-repressive.
  • NO-releasing nanomaterials offer a strategy for sustained, localized NO delivery to tumors.
  • Diverse nanomaterial types show potential for delivering NO to combat tumor cells.

Conclusions:

  • NO-releasing nanomaterials represent a promising strategy for localized cancer therapy.
  • Targeted delivery of high NO concentrations via nanomaterials could enhance tumoricidal effects.
  • Further research into NO-based nanomedicine is warranted for effective cancer treatment.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K